Omkar Pharmachem Limited

OMKARPH

INE501C01015

Investment Holding Companies

Delayed Bombay S.E. Other stock markets 03:30:58 27/06/2024 pm IST			5-day change	1st Jan Change
24 ^INR	0.00%		+4.35%	+10.19%

30/05	Omkar Pharmachem Limited Announces Pankaj Mahadeo Singh Resigns as Company Secretary and Compliance Officer, Effective on June 15,2024	CI
30/05	Omkar Pharmachem Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

Omkar Pharmachem Limited Reports Earnings Results for the First Quarter Ended June 30, 2019

August 14, 2019 at 05:59 pm IST

Omkar Pharmachem Limited announced earnings results for the first quarter ended June 30, 2019. For the first quarter, the company announced net loss was INR 972,000 compared to INR 915,000 a year ago. Basic loss per share was INR 0.0964 compared to INR 0.0907 a year ago.

Latest news about Omkar Pharmachem Limited

Omkar Pharmachem Limited Announces Pankaj Mahadeo Singh Resigns as Company Secretary and Compliance Officer, Effective on June 15,2024	30/05	CI
Omkar Pharmachem Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	30/05	CI
Omkar Pharmachem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02	CI
Omkar Pharmachem Limited Announces Appointment of Arun Kumar as Chief Financial Officer	23/12	CI
Omkar Pharmachem's CFO Resigns	15/12	MT
Omkar Pharmachem Limited Announces the Resignation of Amit Jain from the Post of Chief Financial Officer	15/12	CI
Omkar Pharmachem Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/23/14	CI
Omkar Pharmachem Limited Appoints Amit Jain as Chief Financial Officer	30/23/30	CI
Omkar Pharmachem Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30/23/30	CI
Omkar Pharmachem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	30/23/30	CI
Omkar Pharmachem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/23/14	CI
Omkar Pharmachem Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/22/14	CI
Omkar Pharmachem CFO Resigns	21/22/21	MT
Omkar Pharmachem CFO Resigns	19/22/19	MT
Omkar Pharmachem Limited Announces the Resignation of Gaurav Kathuria as Chief Financial Officer	17/22/17	CI
Omkar Pharmachem Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	11/22/11	CI
Omkar Pharmachem Limited Reports Earnings Results for the Full Year Ended March 31, 2022	30/22/30	CI
Omkar Pharmachem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	30/22/30	CI
Omkar Pharmachem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	14/22/14	CI
Omkar Pharmachem Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	12/21/12	CI
Omkar Pharmachem Limited Approves Shifting of Registered Office	31/21/31	CI
Omkar Pharmachem Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	12/21/12	CI
Omkar Pharmachem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	29/21/29	CI
Omkar Pharmachem Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	12/21/12	CI
Omkar Pharmachem Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	12/20/12	CI

Chart Omkar Pharmachem Limited

Duration

Period

More charts

Company Profile

Omkar Pharmachem Limited is an India-based company. The Company is engaged in the pharmaceuticals and chemicals business. It also provides management and business support services.

Sector

Investment Holding Companies

Calendar

13/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Shell Companies

	1st Jan change	Capi.
OMKAR PHARMACHEM LIMITED	+10.19%	29L
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+109.89%	649.02Cr
APPLE ISPORTS GROUP, INC.	+98.02%	124.97Cr
CHURCHILL CAPITAL CORP VII	+2.95%	99Cr
PERELLA WEINBERG PARTNERS	+26.90%	83Cr
ARES ACQUISITION CORPORATION II	+2.20%	67Cr
E7 GROUP	+3.23%	63Cr
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	60Cr
ADMIRAL ACQUISITION LIMITED	+10.28%	54Cr
CAPITOL INVESTMENT CORP. VII	-.--%	50Cr